Trilostane

CAS 13647-35-3

Em Estoque

Trilostane

Cat. No. ANT-TRL-000CAS 13647-35-3Em Estoque

Dados Técnicos

Cat. No.ANT-TRL-000

CAS13647-35-3

Fórmula Mol.C₂₀H₂₇NO₃

Peso Mol.329.43 g/mol

IUPAC(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile

SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C

InChIInChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1

Chave InChIKVJXBPDAXMEYOA-CXANFOAXSA-N

Pureza99%

Descrição

Visão geral

Trilostane has been used in the treatment of Cushing's syndrome (hypercortisolism), Conn's syndrome (hyperaldosteronism), and postmenopausal breast cancer in humans. When used to treat breast cancer, trilostane is administered in combination with a corticosteroid to prevent glucocorticoid deficiency

A Anant Labs fabrica e fornece impurezas de Trilostane de alta qualidade para o mercado global. Nossas impurezas EP de Trilostane são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Sinônimos

(4alpha,5alpha,17beta)-4,5-Epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrileTrilostane13647-35-3ModrenalVetorylDesopanModrastaneTrilostanoWin-24540Trilostanum

Buscar APIs A–Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Impurezas (1)

Impureza

Trilostane

Cat. No.: ANT-TRL-000

In StockRFQ

Trilostane

Trilostane

Visão geral

Sinônimos

Impurezas (1)

Trilostane

Procurando um padrão de referência específico?